// App-Quantinova.ai

: Relative Efficacy of Treatment Options in Newly Diagnosed Multiple Myeloma: Results from a Systematic Literature Review and Network Meta-Analysis

Researchers

Presenter

  • Karthik Ramasamy

Principal Investigators

  • Howard Thom

  • Vijay K. D'Souza

  • Vanessa Buchanan

  • Sujith Dhanasiri

Medical Centers

  • National Institute for Health Research NIHR Oxford Biomedical Research, Oxford, United Kingdom

  • Oxford University Hospitals NHS Trust, Oxford, United Kingdom

  • University of Bristol, Bristol, United Kingdom

  • Cogentia Healthcare Consulting, Cambridge, United Kingdom

  • Celgene Corporation, Summit, NJ

Locations

  • United Kingdom

  • United States

Companies

  • Celgene Corporation

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Active Comparator

  • Multinational

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved